Ironwood (IRWD) Updates on Q3 Activity; FDA Approves LINZESS, Linaclotide Gets Nod from CHMP
Go back to Ironwood (IRWD) Updates on Q3 Activity; FDA Approves LINZESS, Linaclotide Gets Nod from CHMP| IRONWOOD PHARMA-A (NASDAQ: IRWD) | Delayed: 3.65 +0.02 (0.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.63 | 52 Week High | $16.89 | |||
| Open | $3.65 | 52 Week Low | $7.35 | |||
| Day High | $3.70 | P/E | N/A | |||
| Day Low | $3.58 | EPS | $-2.35 | |||
| Volume | 1,868,682 | |||||
